TABLE 1

Summary of hit activities from the primary high-throughput screen, orthogonal, and counter screen assays

Chemical GroupsNumberCompound IdentificationDNPEPENPEPΔ Activity Score a
Asp-AMC HydrolysisAng II HydrolysisGlu-AMC Hydrolysis
Activity Score (12.3 µM)IC50 (µM)Activity Score (10 µM)IC50 (µM)Activity Score (10 µM)
A 193293b −95.0 ± 1.41.4−93.9 ± 0.60.1−77.8 ± 9.7−16.1
2392425b −87 ± 1.45.0−89.6 ± 0.30.81−87.4 ± 2.5−2.2
B 3897833c −83 ± 0.21.7−55.6 ± 11.3126.5 ± 11.1−62.1
C 498897b −95.7 ± 0.40.54−94.3 ± 0.91.3−71.9 ± 2.2−22.4
5769078b −63.8 ± 2.45.8−92.7 ± 2.40.40−84.4 ± 1.1−8.3
6702610−84.4 ± 1.02.4−93.3 ± 0.62.0−45 ± 7.2−48.3
D 7241320c −74.5 ± 5.24.4−91.8 ± 5.20.26−28.8 ± 8.7−63.0
8705521c −82.5 ± 0.90.16−78.9 ± 4.55.04.5 ± 3.9−83.4
9936427b −83 ± 0.70.83−93.0 ± 1.31.7−89 ± 0.8−4.0
10374081c −87.4 ± 1.22.7−92.2 ± 2.34.75.5 ± 3.4−97.7
11405279−73.6 ± 1.42.3−91.0 ± 2.43.6−45.8 ± 4.9−45.2
12914971−81.8 ± 0.23.1−50.1 ± 6.58.3−22.4 ± 3.1−27.7
13920521b −68.1 ± 2.510.2−59.3 ± 8.918−43.2 ± 2.9−16.1
E 14897927c −74.4 ± 3.15.7−91.7 ± 3.25.7−17.3 ± 2.5−74.4
15251431c −74.7 ± 0.71.6−80.5 ± 4.63.655.5 ± 9.6−136.0
F 16347749b −72.3 ± 0.82.0−90.7 ± 3.61.4−72.8 ± 8.9−17.9
17252185c−81.7 ± 0.73.2−56.0 ± 9.717−0.2 ± 7.5−55.8
G 18505901b −93.4 ± 0.20.84−94.0 ± 1.12.1−83.9 ± 2.0−10.1
19923254−74.6 ± 1.27.7−93.0 ± 2.44.2−44.8 ± 5.3−48.2
20773587−62.8 ± 2.38.0−88.9 ± 2.56.2−61 ± 4.2−27.9
H 21406365c −78.8 ± 0.85.7−75.3 ± 4.03.0−0.8 ± 6.6−74.5
I 22899189−77.4 ± 1.53.2−90.7 ± 4.36.0−64.9 ± 3.8−25.8
23312792b −77.8 ± 1.03.2−87.2 ± 8.72.8−92.7 ± 1.05.5
  • Ang II, angiotensin II; Asp-AMC, L-aspartic acid 7-amido-4-methylcoumarin; DNPEP, aspartyl aminopeptidase; ENPEP, glutamyl aminopeptidase; Glu-AMC, L-glutamic acid 7-amido-4-methylcoumarin.

  • a Δ Activity score = activity scoreDNPEP − activity scoreENPEP, where activity scoreDNPEP is for Ang II hydrolysis.

  • b Dual inhibitors of DNPEP and ENPEP.

  • c DNPEP-selective inhibitors.